Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)
38.88
+0.22 (0.57%)
Jun 11, 2026, 3:00 PM CST
SHA:688314 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 87.81 | 98.7 | 88.4 | 75.51 | 75.69 | 81.63 |
Depreciation & Amortization | 15.25 | 15.25 | 13.5 | 12.31 | 11.82 | 10.63 |
Other Amortization | 2.17 | 2.17 | 3.43 | 3.12 | 2.66 | 1.43 |
Loss (Gain) From Sale of Assets | -0 | -0 | -0.46 | 0.04 | 0 | -0.02 |
Asset Writedown & Restructuring Costs | 2.56 | 2.56 | 1.89 | 0.03 | 0.04 | 0.35 |
Loss (Gain) From Sale of Investments | 9.21 | 9.21 | 12.59 | 1.86 | -3.45 | -2.16 |
Provision & Write-off of Bad Debts | 0.6 | 0.6 | -0.34 | -0 | 0.2 | -0.04 |
Other Operating Activities | 13.91 | 3.92 | 6.5 | 9.65 | 5.55 | 5.37 |
Change in Accounts Receivable | -15.56 | -15.56 | 2.91 | -0.1 | -4.52 | -3.75 |
Change in Inventory | -9.86 | -9.86 | 6.78 | -5.24 | -6.61 | -5.49 |
Change in Accounts Payable | 5.98 | 5.98 | 6.47 | -11.31 | 10.78 | 16.04 |
Change in Other Net Operating Assets | 6.99 | 6.99 | - | - | - | - |
Operating Cash Flow | 117.14 | 118.04 | 140.25 | 85.22 | 91.98 | 103.29 |
Operating Cash Flow Growth | -8.99% | -15.84% | 64.57% | -7.34% | -10.95% | 78.61% |
Capital Expenditures | -59.17 | -51.39 | -47.4 | -14.22 | -18.2 | -55.24 |
Sale of Property, Plant & Equipment | 0.01 | 0 | 0.66 | 0.01 | - | 0.02 |
Cash Acquisitions | -46.84 | -46.84 | -10.78 | - | - | - |
Investment in Securities | -14.69 | -12.79 | -30.64 | -13.82 | -10.07 | 2.48 |
Other Investing Activities | -95.63 | -5.35 | -3.2 | - | - | - |
Investing Cash Flow | -216.32 | -116.37 | -91.36 | -28.04 | -28.27 | -52.74 |
Long-Term Debt Issued | - | 30 | - | - | 15.01 | 4 |
Long-Term Debt Repaid | - | -2.82 | -2.62 | -2.47 | -2.15 | -3.33 |
Net Debt Issued (Repaid) | 26.88 | 27.18 | -2.62 | -2.47 | 12.86 | 0.67 |
Issuance of Common Stock | - | - | - | - | - | 224.6 |
Common Dividends Paid | -32.94 | -32.78 | -42.7 | -31.82 | -36.9 | -30.65 |
Other Financing Activities | -0.03 | -0.37 | -0.63 | 2.5 | -17.4 | -12.13 |
Financing Cash Flow | -6.1 | -5.97 | -45.95 | -31.79 | -41.43 | 182.49 |
Foreign Exchange Rate Adjustments | -0.53 | -0.17 | -0.33 | 0.49 | 1.63 | -0.51 |
Net Cash Flow | -105.81 | -4.46 | 2.62 | 25.88 | 23.91 | 232.53 |
Free Cash Flow | 57.97 | 66.65 | 92.86 | 71 | 73.78 | 48.05 |
Free Cash Flow Growth | -31.95% | -28.22% | 30.78% | -3.76% | 53.56% | - |
Free Cash Flow Margin | 16.94% | 18.98% | 28.84% | 25.82% | 30.75% | 22.61% |
Free Cash Flow Per Share | 0.71 | 0.82 | 1.15 | 0.87 | 0.91 | 0.66 |
Cash Income Tax Paid | 49.45 | 49.8 | 53.96 | 55.05 | 33.71 | 26.83 |
Levered Free Cash Flow | 10.55 | 27.4 | 60.45 | 47.96 | 47.09 | 21.99 |
Unlevered Free Cash Flow | 12.01 | 28.85 | 61.81 | 49.15 | 47.86 | 22.45 |
Change in Working Capital | -14.37 | -14.37 | 14.75 | -17.29 | -0.54 | 6.12 |